Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liver | 13 | 2023 | 7513 | 1.100 |
Why?
|
Follistatin | 3 | 2023 | 137 | 0.950 |
Why?
|
Forkhead Transcription Factors | 6 | 2013 | 1612 | 0.920 |
Why?
|
Sirtuins | 4 | 2016 | 320 | 0.840 |
Why?
|
Insulin Resistance | 7 | 2023 | 3951 | 0.760 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 2022 | 112 | 0.750 |
Why?
|
Insulin | 8 | 2023 | 6588 | 0.680 |
Why?
|
Heat-Shock Proteins | 2 | 2014 | 795 | 0.450 |
Why?
|
Sterol Regulatory Element Binding Protein 2 | 1 | 2013 | 56 | 0.430 |
Why?
|
Homeostasis | 9 | 2023 | 3318 | 0.420 |
Why?
|
Glucose | 8 | 2023 | 4341 | 0.420 |
Why?
|
Proprotein Convertases | 1 | 2013 | 95 | 0.420 |
Why?
|
Hyperglycemia | 2 | 2018 | 1375 | 0.390 |
Why?
|
Nicotinamide Phosphoribosyltransferase | 1 | 2011 | 83 | 0.360 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2013 | 1168 | 0.340 |
Why?
|
Multiprotein Complexes | 1 | 2014 | 1113 | 0.300 |
Why?
|
Serine Endopeptidases | 1 | 2013 | 1022 | 0.300 |
Why?
|
Glucose Intolerance | 3 | 2018 | 575 | 0.280 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2013 | 1116 | 0.280 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2014 | 2455 | 0.260 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2014 | 2057 | 0.250 |
Why?
|
Mice, Knockout | 10 | 2023 | 14393 | 0.240 |
Why?
|
Cholesterol | 1 | 2013 | 2902 | 0.230 |
Why?
|
Cholesterol, LDL | 1 | 2013 | 2380 | 0.230 |
Why?
|
Mice, 129 Strain | 2 | 2013 | 370 | 0.210 |
Why?
|
Insulin Receptor Substrate Proteins | 4 | 2023 | 557 | 0.200 |
Why?
|
Basal Metabolism | 1 | 2023 | 161 | 0.200 |
Why?
|
Mice | 18 | 2023 | 81324 | 0.190 |
Why?
|
alpha 1-Antitrypsin | 1 | 2022 | 167 | 0.190 |
Why?
|
Tacrolimus Binding Proteins | 1 | 2022 | 193 | 0.190 |
Why?
|
Gluconeogenesis | 2 | 2013 | 185 | 0.190 |
Why?
|
Acetylation | 2 | 2013 | 1050 | 0.180 |
Why?
|
Unfolded Protein Response | 1 | 2022 | 234 | 0.170 |
Why?
|
Receptor, Insulin | 1 | 2023 | 836 | 0.170 |
Why?
|
3T3-L1 Cells | 1 | 2018 | 207 | 0.150 |
Why?
|
Lipid Metabolism | 4 | 2021 | 1893 | 0.150 |
Why?
|
Cold Temperature | 1 | 2021 | 783 | 0.140 |
Why?
|
Animals | 18 | 2023 | 168083 | 0.140 |
Why?
|
Mice, Inbred C57BL | 7 | 2019 | 22129 | 0.140 |
Why?
|
Organ Specificity | 3 | 2021 | 1963 | 0.130 |
Why?
|
Adipose Tissue, White | 1 | 2018 | 360 | 0.120 |
Why?
|
Mice, Obese | 3 | 2023 | 418 | 0.120 |
Why?
|
Fibroblast Growth Factors | 1 | 2021 | 863 | 0.120 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 899 | 0.120 |
Why?
|
Adenylate Kinase | 1 | 2014 | 102 | 0.120 |
Why?
|
Fatty Liver, Alcoholic | 1 | 2014 | 36 | 0.110 |
Why?
|
Adaptation, Physiological | 1 | 2021 | 1301 | 0.110 |
Why?
|
Glucose Tolerance Test | 2 | 2016 | 1178 | 0.110 |
Why?
|
Gene Knockdown Techniques | 1 | 2018 | 1602 | 0.110 |
Why?
|
Down-Regulation | 2 | 2018 | 2915 | 0.110 |
Why?
|
Gene Expression Regulation | 4 | 2021 | 11856 | 0.110 |
Why?
|
Adenovirus E4 Proteins | 1 | 2012 | 7 | 0.110 |
Why?
|
Glycolysis | 2 | 2016 | 836 | 0.110 |
Why?
|
Histones | 2 | 2013 | 2570 | 0.110 |
Why?
|
Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2012 | 67 | 0.100 |
Why?
|
NAD | 2 | 2019 | 611 | 0.100 |
Why?
|
Obesity | 3 | 2023 | 12937 | 0.100 |
Why?
|
Promoter Regions, Genetic | 2 | 2013 | 5775 | 0.100 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2022 | 12145 | 0.090 |
Why?
|
Phenylalanine | 1 | 2012 | 364 | 0.090 |
Why?
|
Adenoviruses, Human | 1 | 2012 | 255 | 0.090 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2012 | 303 | 0.090 |
Why?
|
Mice, Transgenic | 2 | 2014 | 9518 | 0.090 |
Why?
|
Gene Knockout Techniques | 1 | 2013 | 799 | 0.090 |
Why?
|
Triglycerides | 3 | 2014 | 2457 | 0.080 |
Why?
|
Vesicular Transport Proteins | 1 | 2012 | 374 | 0.080 |
Why?
|
Sirtuin 1 | 1 | 2010 | 246 | 0.080 |
Why?
|
Blotting, Western | 2 | 2013 | 5033 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 4565 | 0.080 |
Why?
|
Lysine | 1 | 2013 | 983 | 0.080 |
Why?
|
Mitochondria | 2 | 2019 | 3620 | 0.080 |
Why?
|
Insulin-Secreting Cells | 1 | 2016 | 897 | 0.080 |
Why?
|
RNA Interference | 2 | 2014 | 2816 | 0.080 |
Why?
|
Bariatric Surgery | 1 | 2018 | 991 | 0.080 |
Why?
|
Ethanol | 1 | 2014 | 1322 | 0.070 |
Why?
|
HEK293 Cells | 2 | 2013 | 4250 | 0.070 |
Why?
|
Gene Silencing | 1 | 2013 | 1496 | 0.070 |
Why?
|
DNA Repair | 1 | 2016 | 2041 | 0.070 |
Why?
|
Hypercholesterolemia | 1 | 2013 | 1141 | 0.070 |
Why?
|
Fatty Liver | 1 | 2012 | 789 | 0.070 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2010 | 858 | 0.070 |
Why?
|
Signal Transduction | 3 | 2022 | 23415 | 0.060 |
Why?
|
Protein Processing, Post-Translational | 1 | 2013 | 1967 | 0.060 |
Why?
|
Base Sequence | 2 | 2013 | 12404 | 0.060 |
Why?
|
Hepatocytes | 3 | 2021 | 1231 | 0.060 |
Why?
|
Autophagy | 1 | 2012 | 1326 | 0.060 |
Why?
|
Muscle, Skeletal | 1 | 2019 | 4947 | 0.060 |
Why?
|
Phosphorylation | 1 | 2014 | 8303 | 0.050 |
Why?
|
Lipids | 2 | 2012 | 3330 | 0.050 |
Why?
|
Fatty Acids | 1 | 2011 | 1806 | 0.050 |
Why?
|
Hep G2 Cells | 2 | 2014 | 374 | 0.050 |
Why?
|
Gene Expression | 1 | 2013 | 7567 | 0.040 |
Why?
|
Transfection | 3 | 2014 | 5750 | 0.040 |
Why?
|
Adipocytes, Brown | 1 | 2021 | 151 | 0.040 |
Why?
|
Epigenesis, Genetic | 1 | 2013 | 3790 | 0.040 |
Why?
|
Gene Deletion | 2 | 2016 | 2656 | 0.030 |
Why?
|
Aging | 1 | 2016 | 8701 | 0.030 |
Why?
|
Thermogenesis | 1 | 2021 | 474 | 0.030 |
Why?
|
Humans | 8 | 2022 | 761098 | 0.030 |
Why?
|
Adipose Tissue, Brown | 1 | 2021 | 763 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2021 | 2227 | 0.030 |
Why?
|
Crosses, Genetic | 1 | 2016 | 752 | 0.030 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2014 | 103 | 0.030 |
Why?
|
Glucokinase | 1 | 2013 | 102 | 0.030 |
Why?
|
Lipogenesis | 1 | 2014 | 214 | 0.030 |
Why?
|
Microscopy, Electron | 1 | 2016 | 2562 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2021 | 2892 | 0.020 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2014 | 597 | 0.020 |
Why?
|
Body Weight | 1 | 2021 | 4618 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2019 | 2864 | 0.020 |
Why?
|
Pyruvic Acid | 1 | 2010 | 203 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2021 | 3309 | 0.020 |
Why?
|
Islets of Langerhans | 1 | 2016 | 1341 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 2016 | 1866 | 0.020 |
Why?
|
Microtubule-Associated Proteins | 1 | 2014 | 1074 | 0.020 |
Why?
|
Molecular Structure | 1 | 2012 | 1875 | 0.020 |
Why?
|
Feedback, Physiological | 1 | 2010 | 475 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2010 | 849 | 0.020 |
Why?
|
Blood Glucose | 1 | 2021 | 6390 | 0.020 |
Why?
|
Dietary Fats | 1 | 2013 | 1995 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3803 | 0.020 |
Why?
|
Up-Regulation | 1 | 2013 | 4111 | 0.010 |
Why?
|
Oxygen | 1 | 2016 | 4226 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2014 | 18217 | 0.010 |
Why?
|
Transcription Factors | 1 | 2023 | 12096 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2012 | 3388 | 0.010 |
Why?
|
Calcium | 1 | 2016 | 5720 | 0.010 |
Why?
|
Models, Molecular | 1 | 2012 | 5413 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12670 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2013 | 3443 | 0.010 |
Why?
|
Circadian Rhythm | 1 | 2012 | 2570 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 17598 | 0.010 |
Why?
|
DNA | 1 | 2010 | 7189 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2010 | 12743 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2010 | 18926 | 0.010 |
Why?
|
Male | 3 | 2019 | 360675 | 0.010 |
Why?
|
Time Factors | 1 | 2014 | 39953 | 0.010 |
Why?
|
Middle Aged | 1 | 2021 | 220835 | 0.000 |
Why?
|
Concepts
(138)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(8)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_